Elevated transpulmonary gradient and cardiac magnetic resonance-derived right ventricular remodeling predict poor outcomes in sickle cell disease

Haematologica. 2016 Feb;101(2):e40-3. doi: 10.3324/haematol.2015.125229. Epub 2015 Nov 20.

¹ Cardiovascular and Pulmonary Branch, Lung and Blood Institute, Bethesda, MD, USA Division of Cardiology, David Geffen School of Medicine at UCLA and VA Greater Los Angeles Healthcare System, CA, USA.
² Office of Biostatistics Research, National Heart, Lung and Blood Institute, Bethesda, MD, USA.
³ Cardiovascular and Pulmonary Branch, Lung and Blood Institute, Bethesda, MD, USA.
⁴ Sickle Cell Vascular Disease Section, Hematology Branch, Lung and Blood Institute, Bethesda, MD, USA Howard University College of Medicine, Washington, DC, USA.
⁵ Cardiovascular and Pulmonary Branch, Lung and Blood Institute, Bethesda, MD, USA Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY, USA.
⁶ Sickle Cell Vascular Disease Section, Hematology Branch, Lung and Blood Institute, Bethesda, MD, USA.
⁷ Sickle Cell Vascular Disease Section, Hematology Branch, Lung and Blood Institute, Bethesda, MD, USA Division of Hematology/Oncology, Sickle Cell Center, Montefiore Medical Center, New York, NY, USA.
⁸ Sickle Cell Vascular Disease Section, Hematology Branch, Lung and Blood Institute, Bethesda, MD, USA Division of Hematology/Oncology and Adult Sickle Cell Center of Excellence, University of Pittsburgh, PA, USA katogj@upmc.edu.

No abstract available

Keywords: cardiomyopathy; magnetic resonance imaging; pulmonary hypertension; right ventricle; sickle cell disease.

Publication types